马原生动物脑髓炎:一个古老的寄生虫遇到了现代的复杂化
1Bethel Consulting, Lindsay, Oklahoma. Bethel1315@gmail.com.
International journal of pharmaceutical compounding
|March 12, 2026
概括
马原生动物脑髓炎 (EPM) 在马群中很常见,原因是压力和住房. 药剂师管理EPM作为慢性寄生虫抑制,而不是治愈,需要定制的配方策略.
科学领域:
- 马类医学 马类医学
- 寄生虫学的寄生虫学
- 兽医药房 兽医药房 兽医药房
背景情况:
- 马原生动物脑髓炎 (EPM) 是马中的一个重要的神经疾病.
- 由于交通压力,年轻年龄和聚集住房等因素,在赛车人群中患病率很高.
- 目前的商业治疗方法可能并不总是有效或适合所有病例.
研究的目的:
- 为了突出马匹慢性EPM管理的挑战.
- 为了强调从治疗到慢性寄生虫抑制的观点的转变.
- 在商业产品不足时,为EPM管理提供精细的复合策略.
主要方法:
- 对EPM的临床观察和配方开发的审查.
- 对抑制寄生虫的复合策略的分析.
- 评估配方稳定性和客户咨询方法.
主要成果:
- 了解EPM是一种慢性疾病,需要采取不同的方法,而不是治疗治疗.
- 复合配方可以解决商业产品的局限性.
- 精细的策略可以改善马群中EPM的管理.
结论:
- 复合药剂师在治疗慢性EPM方面发挥着至关重要的作用.
- 当商业选择不足时,定制配方是必不可少的.
- 对慢性抑制的范式转变是有效的EPM管理的关键.
更多相关视频
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
1.3K
06:57Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
3.1K
相关概念视频
Pharmaceutical Poisoning: Treatment Strategies
113
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
113
Myasthenia Gravis: Overview and Treatment
3.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.3K
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
